MKI67 and breast cancer: Moreover, a histological analysis of tumor sections revealed that the combination of ZC-22 and cisplatin dramatically suppressed the expression of Ki67 and increased the accumulation of γH2A.X (Figure 6D,E), suggesting that it was an effective strategy for the treatment of breast cancer.